DIAPH3 and glioblastoma: To investigate the mechanism by which sustained IMM02-mediated pharmacological mDia2 agonism functionally disrupts GBM tumor microtube dynamics, we examined protein expression levels in patient-derived GBM spheres treated with IMM02.